University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Broad spectrum vasopressors: A new approach to the initial management of septic shock?

Chawla, L.S., Ostermann, M., Forni, Lui and Tidmarsh, G.F. (2019) Broad spectrum vasopressors: A new approach to the initial management of septic shock? Critical Care, 23 (1).

[img]
Preview
Text
s13054-019-2420-y.pdf - Version of Record

Download (419kB) | Preview

Abstract

The mainstay of hemodynamic treatment of septic shock is fluid resuscitation followed by vasopressors where fluids alone are insufficient to achieve target blood pressure. Norepinephrine, a catecholamine, is the first-line vasopressor used worldwide but given that all routinely used catecholamines target the same adrenergic receptors, many clinicians may add a non-catecholamine vasopressor where refractory hypotension due to septic shock is present. However, the timing of this additional intervention is variable. This decision is based on three key factors: availability, familiarity, and safety profile. In our opinion, further consideration should be potential vasopressor response because following appropriate volume resuscitation, the response to different vasopressor classes is neither uniform nor predictable. Critically ill patients who are non-responders to high-dose catecholamines have a dismal outcome. Similarly, patients have a variable response to non-catecholamine agents including vasopressin and angiotensin II: but where patients exhibit a blood pressure response the outcomes are improved over nonresponders. This variable responsiveness to vasopressors is similar to the clinical approach of anti-microbial sensitivity. In this commentary, the authors propose the concept of “broad spectrum vasopressors” wherein patients with septic shock are started on multiple vasopressors with a different mechanism of action simultaneously while the vasopressor sensitivity is assessed. Once the vasopressor sensitivities are assessed, then the vasopressors are ‘deescalated’ accordingly. We believe that this concept may offer a new approach to the treatment of septic shock.

Item Type: Article
Divisions : Faculty of Health and Medical Sciences > School of Biosciences and Medicine
Authors :
NameEmailORCID
Chawla, L.S.
Ostermann, M.
Forni, Luil.forni@surrey.ac.uk
Tidmarsh, G.F.
Date : 16 April 2019
DOI : 10.1186/s13054-019-2420-y
Copyright Disclaimer : © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Uncontrolled Keywords : Septic shock; Catecholamines; Vasopressin; Angiotensin II; Sensitivity
Depositing User : Diane Maxfield
Date Deposited : 28 Oct 2019 12:35
Last Modified : 28 Oct 2019 12:35
URI: http://epubs.surrey.ac.uk/id/eprint/852703

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800